Mangoceuticals, Inc.
NASDAQ: MGRX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Jacob D. Cohen
- Employees
- 3
- Headquarters
- Dallas, United States
- IPO year
- 2023
- Market cap
- $3.6M
- Website
- https://www.mangorx.com
Loading MGRX…
Loading profile data…Frequently asked questions about MGRX
What does Mangoceuticals, Inc. (MGRX) do?
Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'M...
Where does MGRX trade?
Mangoceuticals, Inc. (MGRX) trades on the NASDAQ Capital Market.
What sector is MGRX in?
Mangoceuticals, Inc. (MGRX) operates in the Healthcare sector, specifically in the Medical - Healthcare Information Services industry.
Who is the CEO of Mangoceuticals, Inc.?
Jacob D. Cohen is the chief executive officer of Mangoceuticals, Inc. (MGRX).
Where is Mangoceuticals, Inc. headquartered?
Mangoceuticals, Inc. is headquartered in United States.
Does MGRX pay a dividend?
Mangoceuticals, Inc. (MGRX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MGRX go public?
Mangoceuticals, Inc. (MGRX) completed its initial public offering in 2023.